OpportunityTitle: Program Expansion Supplement for Support the Implementation and Expansion of High Quality HIV Care, Prevention and Treatment Activities in Central Province in the Republic of Kenya by Engaging Local Indigenous Partners PEPFAR
AdditionalInformationOnEligibility: Eligible applicants that can apply for this funding opportunity are listed below: University of Nairobi (UoN)
Description: The purpose of this program is to provide technical assistance and funding to local indigenous organizations in Kenya to continue and expand comprehensive HIV prevention, care and antiretroviral treatment (ART) programs initiated under the PEPFAR-HHS/CDC centrally funded HIV clinical services and antiretroviral treatment program in predominantly, but not exclusively, public sector health facilities in the Central Province in the Republic of Kenya. Additionally, the purpose of this program is to provide technical and capacity building support to Kenyan organizations that will have responsibility for implementing HIV care and treatment services. This funding opportunity announcement (FOA) covers a wide range of activities within the spectrum of comprehensive HIV services to strengthen the capacity for service delivery and expand activities to maximize coverage. These activities include, but are not limited to, prevention of mother to child transmission (PMTCT), TB/HIV testing and treatment, pediatric and adult care, pediatric and adult treatment, nutrition programs, prevention with positives (PWP), post exposure prophylaxis (PEP), voluntary medical male circumcision (VMMC), behavior change interventions, and HIV counseling and testing activities, specifically provider-initiated testing and counseling (PITC). In addition, in further support of the care provided to patients receiving HIV services, applicants may be allowed to put an emphasis on other medical conditions such as malaria, emerging and re-emerging infections, neglected tropical diseases, influenza, and other diseases with pandemic potential as well as environmental health issues, chronic diseases, maternal and child health, reproductive health, public health preparedness, bio- safety, and injury control and prevention. Under the leadership of the U.S. Global AIDS Coordinator, as part of the President&apos;s Emergency Plan, the U.S. Department of Health and Human Services&#8217; Centers for Disease Control and Prevention (HHS/CDC) works with host countries and other key partners to assess the needs of each country and design a customized program of assistance that fits within the host nation&apos;s strategic plan and partnership framework. HHS/CDC focuses primarily on two or three major program areas in each country. Goals and priorities include the following: Achieving primary prevention of HIV infection through activities such as expanding confidential counseling and testing programs linked with evidence based behavioral change and building programs to reduce mother-to-child transmission; Improving the care and treatment of HIV/AIDS, sexually transmitted infections (STIs) and related opportunistic infections by improving STI management; enhancing laboratory diagnostic capacity and the care and treatment of opportunistic infections; interventions for intercurrent diseases impacting HIV infected patients including tuberculosis (TB); and initiating programs to provide anti-retroviral therapy (ART); Strengthening the capacity of countries to collect and use surveillance data and manage national HIV/AIDS programs by expanding HIV/STI/TB surveillance programs and strengthening laboratory support for surveillance, diagnosis, treatment, disease monitoring and HIV screening for blood safety. Developing, validating and/or evaluating public health programs to inform, improve and target appropriate interventions, as related to the prevention, care and treatment of HIV/AIDS, TB and opportunistic infections.
GrantorContactEmailDescription: Grants Policy
GrantorContactText: Priyanka Rathod&lt;br/&gt;wnv9@cdc.gov&lt;br/&gt;
CloseDateExplanation: Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.